Aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial

Journal of Cardiovascular Disease Research

Volumn 3, Issue 3, 2012, Pages 185-190

  Zeb, Irfan ^a   Ahmadi, Naser ^a   Nasir, Khurram ^b   Kadakia, Jigar ^a   Larijani, Vahid Nabavi ^a   Flores, Ferdinand ^a   Li, Dong ^a   Budoff, Matthew J ^a  

^a UCLA MEDICAL CENTER   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

Aged garlic extract; atherosclerosis; coenzyme Q10; inflammatory markers

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; GARLIC EXTRACT; GARLIC EXTRACT PLUS COENZYME Q10; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO; UBIDECARENONE; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARDIOVASCULAR RISK; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY CALCIFICATION; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DOWN REGULATION; DRUG MECHANISM; DRUG SCREENING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TREATMENT OUTCOME;

EID: 84864720069     PISSN: 09753583     EISSN: 09762833     Source Type: Journal    
DOI: 10.4103/0975-3583.98883     Document Type: Article

References (30)

1. Fauci A BE, Kasper D. The Pathogenesis, Prevention, and Treatment of Atherosclerosis. Harrison s Principles of Internal Medicine. McGraw- Hill Companies Inc.; 2008.
2. Budoff MJ, Takasu J, Flores FR, Niihara Y, Lu B, Lau BH, et al. Inhibiting progression of coronary calcification using Aged Garlic Extract in patients receiving statin therapy: A preliminary study. Prev Med 2004;39:985-91.
3. Budoff MJ, Ahmadi N, Gul KM, Liu ST, Flores FR, Tiano J, et al. Aged garlic extract supplemented with B vitamins, folic acid and L-arginine retards the progression of subclinical atherosclerosis: A randomized clinical trial. Prev Med 2009;49:101-7.
4. Campbell JH, Efendy JL, Smith NJ, Campbell GR. Molecular basis by which garlic suppresses atherosclerosis. J Nutr 2001;131:1006S-9
5. Gonen A, Harats D, Rabinkov A, Miron T, Mirelman D, Wilchek M, et al. The antiatherogenic effect of allicin: possible mode of action. Pathobiology 2005;72:325-34.
6. Ho SE, Ide N, Lau BH. S-allyl cysteine reduces oxidant load in cells involved in the atherogenic process. Phytomedicine 2001;8:39-46.
7. Morihara N, Sumioka I, Moriguchi T, Uda N, Kyo E. Aged garlic extract enhances production of nitric oxide. Life Sci 2002;71:509-17.
8. Steiner M, Khan AH, Holbert D, Lin RI. A double-blind crossover study in moderately hypercholesterolemic men that compared the effect of aged garlic extract and placebo administration on blood lipids. Am J Clin Nutr 1996;64:866-70.
9. Okuhira M HH, Sandhu R, Steiner M. Modication of Cardiovascular Risk Factors Aged Garlic Extract (AGE). Phytomedicine 2000;7:49-50.
10. Rahman K, Billington D. Dietary supplementation with aged garlic extract inhibits ADP-induced platelet aggregation in humans. J Nutr 2000;130:2662-5.
11. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-43.
12. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002;347: 1557-65.
13. Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2010;56:e50-103.
14. Ernster L, Dallner G. Biochemical, physiological and medical aspects of ubiquinone function. Biochim Biophys Acta 1995;1271:195-204.
15. Ernster L, Forsmark-Andree P. Ubiquinol: An endogenous antioxidant in aerobic organisms. Clin Investig 1993;71:S60-5.
16. Kagan VE, Serbinova EA, Koynova GM, Kitanova SA, Tyurin VA, Stoytchev TS, et al. Antioxidant action of ubiquinol homologues with different isoprenoid chain length in biomembranes. Free Radic Biol Med 1990;9:117-26.
17. Yalcin A, Kilinc E, Sagcan A, Kultursay H. Coenzyme Q10 concentrations in coronary artery disease. Clin Biochem 2004;37:706-9.
18. Hanaki Y, Sugiyama S, Ozawa T, Ohno M. Coenzyme Q10 and coronary artery disease. Clin Investig 1993;71:S112-5.
19. Tomasetti M, Alleva R, Solenghi MD, Littarru GP. Distribution of antioxidants among blood components and lipoproteins: Significance of lipids/CoQ10 ratio as a possible marker of increased risk for atherosclerosis. Biofactors 1999;9:231-40.
20. Shewan LG, Coats AJS. Ethics in the authorship and publishing of scientific articles. Int J Cardiol 2010;144:1-2.
21. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990;15:827-32.
22. Ahmadi N, Tsimikas S, Hajsadeghi F, Saeed A, Nabavi V, Bevinal MA, et al. Relation of oxidative biomarkers, vascular dysfunction, and progression of coronary artery calcium. Am J Cardiol 2010;105:459-66.
23. Gopal A, Nasir K, Liu ST, Flores FR, Chen L, Budoff MJ. Coronary calcium progression rates with a zero initial score by electron beam tomography. Int J Cardiol 2007;117:227-31.
24. Thurlbeck WM, Haines JR. Bronchial dimensions and stature. Am Rev Respir Dis 1975;112:142-5.
25. Budoff MJ, Yu D, Nasir K, Mehrotra R, Chen L, Takasu J, et al. Diabetes and progression of coronary calcium under the influence of statin therapy. Am Heart J 2005;149:695-700.
26. Digiesi V, Cantini F, Oradei A, Bisi G, Guarino GC, Brocchi A, How to cite this article: Zeb I, Ahmadi N, Nasir K, Kadakia J, Larijani VN, Flores F, et al. Aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial. J Cardiovasc Dis Res 2012;3:185-90
27. Source of Support: Wakunaga of America to Dr. Budoff, the manufacturer of AGE and CoQ10, Conflict of Interest: None declared. et al. Coenzyme Q10 in essential hypertension. Mol Aspects Med 1994;15(Suppl):s257-63.
28. Singh RB, Neki NS, Kartikey K, Pella D, Kumar A, Niaz MA, et al. Effect of coenzyme Q10 on risk of atherosclerosis in patients with recent myocardial infarction. Mol Cell Biochem 2003;246:75-82.
29. Witting PK, Pettersson K, Letters J, Stocker R. Anti-atherogenic effect of coenzyme Q10 in apolipoprotein E gene knockout mice. Free Radic Biol Med 2000;29:295-305.
30. Kunadharaju K, Smith TD, DeJoy DM. Line-of-duty deaths among U.S. firefighters: An analysis of fatality investigations. Accid Anal Prev 2011;43:1171-80.